Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease.

JSON

Mattisson IY, Björkbacka H, Wigren M, Edsfeldt A, Melander O, Fredrikson GN, Bengtsson E, Gonçalves I, Orho-Melander M, Engström G, Almgren P, Nilsson J

EBioMedicine 26 (-) 187-197 [2017-12-00; online 2017-11-24]

Affinity Proteomics Stockholm [Service]

Affinity Proteomics Uppsala [Service]

Clinical Biomarkers [Service]

PubMed 29208468

DOI 10.1016/j.ebiom.2017.11.023

Crossref 10.1016/j.ebiom.2017.11.023

pii: S2352-3964(17)30466-8
pmc: PMC5836474